alexa HIV-Infected Men with an Elevated Level of Serum Cystatin C have a High Likelihood of Developing Cancers
ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

HIV-Infected Men with an Elevated Level of Serum Cystatin C have a High Likelihood of Developing Cancers

Naoki Yanagisawa1, Minoru Ando1,2*, Ken Tsuchiya1 and Kosaku Nitta1

1Department IV of Internal Medicine, Tokyo Women’s Medical University, Tokyo, Japan

2Department of Nephrology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan

*Corresponding Author:
Minoru Ando
Department of Nephrology
TokyoMetropolitan Komagome Hospital
Honkomagome, Bunkyo-Ku
Tokyo 113-0021,Japan
Tel: +81-3-3823-2101
Fax: +81-3-3824-1552
E-mail:
hdcn@cick.jp

Received Date: March 19, 2012; Accepted Date: April 21, 2012; Published Date:April 23, 2012

Citation: Yanagisawa N, Ando M, Tsuchiya K, Nitta K (2012) HIV-Infected Men with an Elevated Level of Serum Cystatin C have a High Likelihood of Developing Cancers. J Antivir Antiretrovir 4: 038-042. doi: 10.4172/jaa.1000044

Copyright: ©2012 Yanagisawa N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Background: HIV-infected individuals are at high risk for morbidity and mortality regardless of good infection control with highly active antiretroviral therapy (HAART). The residual inflammation after apparent good infection control with HAART may be responsible for an increased risk of mortality including cancers. Serum cystatin C is not only a sensitive marker for renal dysfunction but also a potential marker for inflammation, which may suggest that this marker is something more than a measure of renal function.
Materials and methods: A total of 520 HIV-infected men under good infection control with HAART were enrolled in a 3-year prospective cohort study. The incidence of cancers was investigated with special reference to serum cystatin C level. Cumulative incidence of cancers over time was analyzed by Kaplan-Meier methods. A Cox proportional hazards model was used to calculate the Hazard Ratio (HR) of developing cancers, adjusted for age, smoking habit, CD4 cell count, serum albumin, estimated glomerular filtration rate below 60 mL/min/1.73m2, C-reactive protein, and presence of comorbidities including diabetes mellitus, hypertension, and hepatic viral infection.
Results: During the follow-up, cancers developed in 14 (2.7%) subjects. Death occurred in 4 from cancers. The Kaplan-Meier estimate for cancer incidence significantly increased in patients with serum cystatin C elevation (≥ 1.0 mg/L). The HR (95% confidence interval) of cancer incidence was 3.56 (1.08-11.2) for elevation of serum cystatin C, although other markers of inflammation were not significant.
Conclusion: The examination of serum cystatin C may enable earlier recognition of cancers among HIV infected individuals.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

agriaquaculture@omicsonline.com

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

biochemjournals@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

chemistryjournals@omicsonline.com

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

clinicaljournals@omicsonline.com

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjournals@omicsonline.com

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

nutritionjournals@omicsonline.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

generalscience@omicsonline.com

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

geneticsmolbio@omicsonline.com

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immunomicrobiol@omicsonline.com

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

nursinghealthcare@omicsonline.com

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicaljournals@omicsonline.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuropsychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

pharmajournals@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords